We are live on
!
Find out more
AIP
ARS Investment Partners Portfolio holdings
AUM
$2.29B
1-Year Est. Return
113.95%
This Fund
S&P 500
This Quarter
Est. Return
+8.47%
1 Year Est. Return
+113.95%
3 Year Est. Return
+260.1%
5 Year Est. Return
+332.48%
10 Year Est. Return
+1,634.5%
AUM
$776M
AUM Growth
+$52.3M
(+7.2%)
Cap. Flow
-$2.62M
Cap. Flow
% of AUM
-0.34%
Top 10 Holdings %
Top 10 Hldgs %
32.35%
Holding
160
New
11
Increased
54
Reduced
57
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$5.5M |
| 2 |
CELG
Celgene Corp
CELG
|
+$5.34M |
| 3 |
CY
Cypress Semiconductor
CY
|
+$5.06M |
| 4 |
Biogen
BIIB
|
+$4.64M |
| 5 |
Amgen
AMGN
|
+$3.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$8.32M |
| 2 |
Skyworks Solutions
SWKS
|
+$5.72M |
| 3 |
Lowe's Companies
LOW
|
+$4.64M |
| 4 |
IBM
IBM
|
+$3.45M |
| 5 |
SPA
Sparton
SPA
|
+$2.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.64% |
| 2 | Industrials | 12.88% |
| 3 | Communication Services | 11.38% |
| 4 | Healthcare | 9.87% |
| 5 | Consumer Discretionary | 6.3% |
Similar funds
AFM
LCM
RA
NFA
MA
ST
GCP
LCM
ARS Investment Partners's Q3 2017 Portfolio in Review
As of Q3 2017, ARS Investment Partners held 160 positions worth $776M, up 7.2% from $724M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
ARS Investment Partners's Q3 2017 filing shows 11 new, 54 increased, 57 reduced and 8 closed positions. Its largest new stake was Biogen: 15,671 shares worth $4.91M. The largest sale was Medtronic, an estimated $8.32M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Industrials and Communication Services.
- ARS Investment Partners's largest Q3 2017 buy was Biogen: 15,671 shares worth $4.91M.
- ARS Investment Partners added most to Citigroup in Q3 2017, an estimated $5.5M increase.
- ARS Investment Partners's biggest Q3 2017 reduction was Lowe's Companies, cutting an estimated $4.64M.
- ARS Investment Partners fully exited Medtronic in Q3 2017, selling an estimated $8.32M.
- ARS Investment Partners's ten largest holdings make up 32% of its $776M portfolio in Q3 2017.
- ARS Investment Partners opened 11 new positions and closed 8 in Q3 2017.
- ARS Investment Partners's portfolio value rose 7.2% quarter-over-quarter to $776M.
Based on ARS Investment Partners's 13F filing for Q3 2017, filed 14 Nov 2017.